LINC01419 promotes cell proliferation and metastasis in hepatocellular carcinoma by enhancing NDRG1 promoter activity.
Hao DangLing ChenPing TangXuefei CaiWenlu ZhangRenfei ZhangAilong HuangHua TangPublished in: Cellular oncology (Dordrecht) (2020)
From our data we conclude that LINC01419 acts clinically, functionally and mechanistically oncogenic in HCC. LINC01419 may, therefore, serve as a promising prognostic indicator and therapeutic target for HCC.